Jemperli
GSK’s Jemperli Shows Promise in Endometrial Cancer Trial – FDA Label Expansion on the Horizon
Anika Sharma
GSK has achieved a significant milestone with its PD-1 inhibitor, Jemperli, in the treatment of endometrial cancer, potentially opening the ...
ESMO 2023: GSK’s Jemperli beats Merck’s Keytruda in lung cancer survival trial
Anika Sharma
In a groundbreaking clinical trial, GSK has achieved remarkable patient survival results with its PD-1 inhibitor, Jemperli, when compared to ...
Endometrial Cancer Patients Get New Option with Jemperli
SG Tylor
Source – GSK GSK has secured approval from the US for Jemperli, in combination with chemotherapy, as a first-line treatment ...
